SEC
Filing

SEC Filing Details

Document Details

Filing Date
Oct 18, 2017
Document Date
Jun 30, 2017
Form Description
Amendment to a previously filed 10-Q
Filing Group
Quarterly Filings
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe